India is rapidly establishing itself as a global hub for neutraceutical active pharmaceutical ingredient development, driven by a combination of factors including competitive costs, a skilled labor pool, and supportive government regulations. Numerous firms are now focusing on the synthesis and provision of these crucial ingredients used in dietary